FDA Approves Cervical-Cancer-Related HPV Test

The FDA has approved a new test for the human papilloma virus (HPV). The new test, which is called the Onclarity™ HPV assay, can detect the genotypes likely to cause cervical cancer in women.Developed by BD Diagnostic Systems, the new test can identify 14 HPV genotypes, including HPV types 16, 18, and 45—which are associated with the majority of cervical cancer cases and 94% of glandular cervical cancer cases. It utilizes the BD SurePath liquid biopsy cytology vial during a cervical